Flora bakteryjna przewodu pokarmowego – objawy dysbiozy, diagnostyka i metody odtwarzania

The human gastrointestinal tract, which can extend up to nine meters in length, hosts a intricate ecosystem populated by billions of microorganisms. Bacterial colonization initiates at birth and encompasses not only the digestive system—from the oral cavity to the colon—but also the skin and mucosal surfaces of the respiratory tract. The composition of the microbiota undergoes continuous transformations throughout an individual’s lifespan, influenced by factors such as age, dietary patterns, antibiotic exposure, intestinal motility (peristalsis), and bacterial metabolic byproducts. Research confirms that the initial microbial colonization occurs during delivery, with its nature contingent upon the mode of birth: in vaginal deliveries, strains such as *Lactobacillus* and *Prevotella*—derived from the maternal vaginal microbiome—predominate, whereas infants born via cesarean section exhibit a microbiota characterized by *Staphylococcus*, *Corynebacterium*, and *Propionibacterium* species. Another pivotal determinant shaping an infant’s microbial community is the feeding method: breastfeeding promotes the proliferation of *Lactobacillus* and *Bifidobacterium*, while formula feeding results in a gut microbiota resembling that of adults [1].

Dysbiosis—a disruption in the microbial equilibrium of the intestine stemming from alterations in the species composition of resident gut bacteria—results in an overproliferation of pathogenic microbial populations, thereby compromising the mucosal barrier integrity of the gastrointestinal tract. Consequently, the organism becomes more vulnerable to infections of viral, bacterial, and fungal origin. The presence of specific bacterial strains may predispose individuals to the development of pathological conditions, including chronic inflammatory bowel diseases (such as Crohn’s disease and ulcerative colitis), gastrointestinal malignancies, allergic hypersensitivity reactions, or metabolic disorders leading to obesity, as evidenced by scientific research [3, 4, 5]. An aberrant immune response to gut-derived antigens can trigger autoimmune processes, including nonspecific inflammatory bowel diseases (IBD), often rooted in a loss of tolerance toward commensal microbial flora. Clinical manifestations encompass abdominal pain of varying severity, weight loss, and alterations in bowel movement frequency and stool consistency. Dysbiosis is also closely associated with irritable bowel syndrome (IBS), characterized by bloating, abdominal discomfort, and irregular defecation patterns. Disruptions in the gut-brain axis may further contribute to extraintestinal symptoms, such as depressive episodes, anxiety disorders, or chronic fatigue. Key risk factors for dysbiosis include: female sex, younger age, a diet rich in saturated fats and refined carbohydrates, chronic use of antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and proton pump inhibitors (PPIs), persistent psychological stress, nicotine dependence, alcohol abuse, and recurrent infections. Symptoms indicative of compromised intestinal barrier function include: recurrent gastrointestinal complaints (diarrhea, vomiting, heartburn, dyspepsia), heightened susceptibility to infections, allergic reactions, autoimmune diseases, depressed mood, chronic fatigue, and anxiety states [6].

A thorough evaluation of gut microbiota composition serves as a valuable adjunct to diagnostic protocols for a spectrum of metabolic, immunological, and digestive disorders. This type of analysis is particularly warranted for individuals exhibiting symptoms suggestive of irritable bowel syndrome (IBS), as well as patients with confirmed food allergies or atopic conditions who experience recurrent infectious episodes alongside chronic gastrointestinal complaints—including persistent diarrhea of unknown origin, recurrent abdominal bloating, irregular bowel movements with a tendency toward constipation, or stools of variable consistency [7]. The contemporary landscape of laboratory diagnostics provides an extensive array of advanced microbiological assays grounded in qualitative and quantitative assessments of key bacterial and fungal populations inhabiting the intestinal lumen. Through the application of cutting-edge molecular techniques, it becomes possible to precisely ascertain the degree of microbial imbalance (dysbiosis) and to identify potentially pathogenic strains. The primary biological specimens for these analyses comprise a fecal sample—evaluated for pH reaction and physical properties such as consistency—and urine, within which the profile of organic acids derived from microbial metabolic activity is examined. An expanded iteration of the test may further incorporate an assessment of intestinal mucosal integrity and digestive efficiency, thereby facilitating a comprehensive approach to the diagnosis of gastrointestinal dysfunctions.

The restoration of gut microbiota equilibrium necessitates comprehensive lifestyle modifications, with an emphasis on a nutrient-dense diet rich in bioactive compounds alongside targeted supplementation with probiotics and prebiotics. A foundational component is the consumption of high-fiber foods—both soluble (inulin, pectins) and insoluble—derived from whole grains, vegetables, fruits, legumes, and seeds. Fermented dairy products such as kefir, live-culture yogurt, and buttermilk, as well as lacto-fermented vegetables (sauerkraut, pickles), provide viable bacterial strains essential for microbial diversity. Processed foods, artificial sweeteners, and refined sugars should be minimized, as they adversely affect microbiota composition. Polyphenols—compounds with anti-inflammatory and antioxidant properties—promote the proliferation of beneficial bacterial species; they are abundant in berries, vegetables, herbs (turmeric, rosemary), spices, dark chocolate, and extra virgin olive oil. Research indicates that while the microbiota gradually recovers post-antibiotic treatment, this process can be significantly accelerated through strategic probiotic intervention. Disruptions to gut flora—triggered by factors such as cesarean deliveries, low-fiber diets, or chronic stress—may manifest as bloating, diarrhea, malaise, and an elevated risk of inflammatory bowel diseases (e.g., ulcerative colitis). An optimal dietary regimen integrating fiber, polyphenols, and probiotics serves as the cornerstone for both therapeutic and preventive approaches to microbiota imbalance.